Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael M Lederman

Showing results (181-190 of 303) with videos related to

Pageof 31
Sort By:
The Journal of Infectious Diseases|May 6, 2014
Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatmentAllan R Tenorio, Yu Zheng, Ronald J Bosch, et al.
Journal of Virology|November 27, 2004
Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infectionMaureen P Martin, Michael M Lederman, Holli B Hutcheson, et al.
Immunology|April 23, 2013
Circulating CD4(+) and CD8(+) T cells are activated in inflammatory bowel disease and are associated with plasma markers of inflammationNicholas T Funderburg, Samantha R Stubblefield Park, Hannah C Sung, et al.
Open Forum Infectious Diseases|February 11, 2022
Monitoring Circulating Immune Checkpoint Proteins as Predictors of Non-AIDS Morbid Events in People With HIV Initiating Antiretroviral TherapyThomas A Premeaux, Carlee B Moser, Ashley McKhann, et al.
AIDS (London, England)|September 28, 2002
Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced diseaseHernan Valdez, Elizabeth Connick, Kimberly Y Smith, et al.
AIDS (London, England)|January 18, 2013
Dendritic cell recruitment in response to skin antigen tests in HIV-1-infected individuals correlates with the level of T-cell infiltrationFrank Liang, Emily Bond, Kerrie J Sandgren, et al.
AIDS (London, England)|October 23, 2003
Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replicationMiguel E Quiñones-Mateu, Michael M Lederman, Zhimin Feng, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 4, 2015
Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte ActivationDavid A Zidar, Steven Juchnowski, Brian Ferrari, et al.
Journal of Leukocyte Biology|April 13, 2017
CD56<sup>bright</sup> NK IL-7Rα expression negatively associates with HCV level, and IL-7-induced NK function is impaired during HCV and HIV infectionsChelsey J Judge, Lenche Kostadinova, Kenneth E Sherman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 20, 2013
Plasma proteome analysis reveals overlapping, yet distinct mechanisms of immune activation in chronic HCV and HIV infectionsDaniela M Schlatzer, Julia M Sugalski, Yanwen Chen, et al.
Pageof 31

Showing results (181-190 of 303) with videos related to

Sort By:
Pageof 31
The Journal of Infectious Diseases|May 6, 2014
Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatmentAllan R Tenorio, Yu Zheng, Ronald J Bosch, et al.
Journal of Virology|November 27, 2004
Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infectionMaureen P Martin, Michael M Lederman, Holli B Hutcheson, et al.
Immunology|April 23, 2013
Circulating CD4(+) and CD8(+) T cells are activated in inflammatory bowel disease and are associated with plasma markers of inflammationNicholas T Funderburg, Samantha R Stubblefield Park, Hannah C Sung, et al.
Open Forum Infectious Diseases|February 11, 2022
Monitoring Circulating Immune Checkpoint Proteins as Predictors of Non-AIDS Morbid Events in People With HIV Initiating Antiretroviral TherapyThomas A Premeaux, Carlee B Moser, Ashley McKhann, et al.
AIDS (London, England)|September 28, 2002
Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced diseaseHernan Valdez, Elizabeth Connick, Kimberly Y Smith, et al.
AIDS (London, England)|January 18, 2013
Dendritic cell recruitment in response to skin antigen tests in HIV-1-infected individuals correlates with the level of T-cell infiltrationFrank Liang, Emily Bond, Kerrie J Sandgren, et al.
AIDS (London, England)|October 23, 2003
Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replicationMiguel E Quiñones-Mateu, Michael M Lederman, Zhimin Feng, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 4, 2015
Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte ActivationDavid A Zidar, Steven Juchnowski, Brian Ferrari, et al.
Journal of Leukocyte Biology|April 13, 2017
CD56<sup>bright</sup> NK IL-7Rα expression negatively associates with HCV level, and IL-7-induced NK function is impaired during HCV and HIV infectionsChelsey J Judge, Lenche Kostadinova, Kenneth E Sherman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 20, 2013
Plasma proteome analysis reveals overlapping, yet distinct mechanisms of immune activation in chronic HCV and HIV infectionsDaniela M Schlatzer, Julia M Sugalski, Yanwen Chen, et al.
Pageof 31